Response of breast cancer cells to anti-HER2 therapy is suppressed when S-nitrosothiol homeostasis is impaired.
Altered S-nitrosothiol homeostasis constitutes a mechanism of resistance to anti-HER2 therapy in breast cancer.
Mechanisms controlling S-nitrosothiol homeostasis may be important prognostic and predictive factors in breast cancer.